Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Celldex Therapeutics Inc
NASDAQ:CLDX
Celldex Therapeutics Inc
NASDAQ:CLDX
Price:
29.345
USD
0.15%
Market Cap:
$2.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
Frontera Energy Corp
F:3PY3
|
CA |
|
Latecoere SA
PAR:LAT
|
FR |
|
Notorious Pictures SpA
F:2FK
|
IT |
Wall St Price Targets
CLDX Price Forecast
Based on 16 analysts
Based on 16 analysts
+122% Upside
from
$29.345
today
Celldex Therapeutics Inc (CLDX)’s 12-month stock price forecast through October 2027 has a consensus target of $65.28, implying 122% upside. The forecast is based on price targets from 16 Wall Street analysts.
CLDX Analyst Rating
Based on 15 analysts
Based on 15 analysts
Analysts rate CLDX Strong buy, with 14 of 15 recommending Buy or Strong buy.
Celldex Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLDX's stock price target?
Price Target
65.28
USD
65.28
USD
According to Wall Street analysts, the average 1-year price target for CLDX is 65.28 USD with a low forecast of 28.28 USD and a high forecast of 105 USD.
What is the Revenue forecast for Celldex Therapeutics Inc?
Projected CAGR
147%
147%
Over the last 13 years, the compound annual growth rate for Revenue has been -14%. The projected CAGR for the next 8 years is 147%.